LETTERS TO THE EDITOR ## Epstein-Barr virus associated antibody patterns Dear Sir, Johansson et al. in their paper: ' I Epstein-Barr virus-associated antibody patterns. . . 11. Chronic lymphocytic leukemia and lymphocytic lymphoma ", state that the reactivity found in sera from patients with Iymp
Epstein–Barr virus-associated malignancies: epidemiologic patterns and etiologic implications
✍ Scribed by Joe L Hsu; Sally L Glaser
- Book ID
- 104374952
- Publisher
- Elsevier Science
- Year
- 2000
- Tongue
- English
- Weight
- 297 KB
- Volume
- 34
- Category
- Article
- ISSN
- 1040-8428
No coin nor oath required. For personal study only.
✦ Synopsis
Epstein-Barr virus (EBV), a ubiquitous B-lymphotrophic herpesvirus, has been found in the tumor cells of a heterogeneous group of malignancies (Burkitt's lymphoma, lymphomas associated with immunosuppression, other non-Hodgkin's lymphomas, Hodgkin's disease, nasopharyngeal carcinoma, gastric adenocarcinoma, lymphoepithelioma-like carcinomas, and immunodeficiency-related leiomyosarcoma). As the epidemiologic characteristics of these cancers have not been considered together, this review seeks to relate their incidence patterns and risk factors to EBV biology and virus-host interaction in an attempt to help elucidate factors involved in EBV-related carcinogenesis. We include a brief review of EBV virology and primary infection to provide a biologic context for considering the epidemiology, summarize the most salient epidemiologic features of each malignancy, synthesize epidemiologic data by risk factor to uncover commonalities and informative contrasts across the diseases, and propose hypotheses regarding etiologic mechanisms, based on the possible effect of the risk factors at various stages in the viral life cycle.
📜 SIMILAR VOLUMES
## Abstract Expression of different panels of latent gene transcripts is controlled by usage of three distinct Epstein‐Barr virus (EBV) nuclear antigen (EBNA) promoters (Wp, Cp, and Qp). EBV‐associated hemophagocytic syndrome, which is often a fatal disease and generally occurs after primary EBV in
Hodgkin's disease (HD) has long been suspected to have an infectious precursor, and indirect evidence has implicated Epstein-Barr virus (EBV), a ubiquitous herpesvirus, as a causal agent. Recent molecular studies using EBER in situ hybridization or latency membrane protein-1 (LMP-1) immunohistochemi
## Abstract Sera from Swedish patients with Hodgkin's disease as well as control sera from donors without known disease were titrated for antibodies to the Epstein‐Barr virus (EBV) by the indirect immunofluorescence technique. In the same sera antibodies capable of blocking the direct membrane immu